The Challenge
Globally, dementia affects millions, eroding capacity for learning and recall, the “me”-ness of personality, and critical functions of daily cognitive interaction. It is a prevalent part of PASC, the post-acute sequaelae conditioning following infection. After infection, the condition progresses, and emerges as a profound burden not only on those diagnosed but also on their families and caregivers. Traditional therapeutic approaches offer limited relief and fail to halt the disease's progression, highlighting the urgent need for innovative treatment strategies.
Our Innovative Solution
Mosae Zorg Industries, B.V. is redefining dementia care through our novel chewing gum formulation, designed to combat cognitive decline through advanced biopharmaceutical technology. Our approach emphasizes personalized products whose ingredients target and clear the underlying source of damage - even starvation - of neurons that are essential to supply and growth of networks of cognition and decision-making, at all ages. We not only aim to prevent dementia’s progression and improve life quality but also to give the central nervous system’s own immunity the opportunity to recover dramatically.
How It Works
Our chewing gum combines ingredients that have nano-compounds specifically proven to clear coinfectious byproducts. This will enhance neuronal function by stopping the accumulation of these by-products and their pathogenic manufacturers. Regular use supports restoration of cognitive health, mitigating the symptoms of dementia by restoring the immunometabolism of healthy epithelial, mucosal and neuronal cells, and certainly reducing local inflammation and the arrival of damage and injury from neurotoxins in salivary glands and the oral cavity. This product stands at the forefront of ecological and sustainable dementia care, offering hope for a brighter future.
Exclusive Member Access
Join our mission to transform dementia treatment and gain exclusive access to our cutting-edge research, product developments, and a community dedicated to advancing cognitive health. Members receive firsthand updates and opportunities to participate in clinical trials, making a direct impact on the future of dementia care.
Testimonials
"Knowing that there can be measurable and visible improvements in cognitive functions has been incredibly encouraging. Mosae Zorg Industries, B.V.'s innovative gum products are not only able to do so at any stage of post-infectious dementia but also , demonstrates that our environent is vitally connected to our health." - Hanna Campbell, CIO & Co-founder
Join Us
Your support propels our products-to-market progress, bringing us closer to a world where post-infectiousness no longer means dementia decline. Join us as a member today, and be part of the pioneering effort to redefine dementia treatment through sustainable, innovative care.